Capha Pharmaceuticals Inc.
FPSUF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $9 | $9 | $9 | $9 |
| - Cash | $3 | $1 | $1 | $1 |
| + Debt | $590 | $560 | $560 | $541 |
| Enterprise Value | $595 | $568 | $569 | $548 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$15 | -$9 | -$19 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$15 | -$9 | -$20 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | -100% | 66.7% | -50% | – |
| Operating Cash Flow | -$20 | $1 | -$20 | -$11 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$20 | $1 | -$20 | -$11 |